Pages that link to "Q54313247"
Jump to navigation
Jump to search
The following pages link to Subconjunctival injection of XG-102, a JNK inhibitor peptide, in patients with intraocular inflammation: a safety and tolerability study. (Q54313247):
Displaying 8 items.
- Inhibition of regulated cell death by cell-penetrating peptides (Q26751423) (← links)
- Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma (Q37735660) (← links)
- Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging (Q38710688) (← links)
- The c-jun N-terminal kinase plays a key role in ocular degenerative changes in a mouse model of Alzheimer disease suggesting a correlation between ocular and brain pathologies. (Q47095979) (← links)
- Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development (Q51653926) (← links)
- Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety (Q92043306) (← links)
- Selective inhibitors for JNK signalling: a potential targeted therapy in cancer (Q93028197) (← links)
- Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity (Q107476758) (← links)